ABSTRACT
Glutamate transporter EAAC1 removes excitatory neurotransmitter in central nervous system, and also absorbs glutamate in epithelia of intestine, kidney, liver and heart for normal cell growth. When a mouse cDNA was screened using EAAC1 cDNA fragment as probe in our lab, a transcript (GenBank U75214) encoding an EAAC1 protein with 148 residues truncated at N-terminal was cloned and named as EAAC2. Sequence analysis shows that EAAC2 has it's own start code and unique 5′TR that is different from that of EAAC1. A mouse genomic library was screened and a positive clone including EAAC1 CDS was sequenced (GenBank AF 322393) and indicates that normal EAAC1 transcript (GenBank U73521) is transcribed from 10 exons in terms of exon I, II, III, IV, V, VI, VII, VIII, IX, X, and EAAC2 transcript is consisted by exons from IV to IX as same as that of EAAC1 and with its unique exon β upstream to exon IV and exon d downstream to IX. EAAC2 transcript has a cluster of transcriptional start sites not overlapping with the transcriptional start sites of EAAC1. These results indicate that EAAC2 is transcribed from an independent promoter but not an alternative splicing event.
Similar content being viewed by others
INTRODUCTION
Glutamate transporters are able to uptake neurotransmitter glutamate from synaptic cleft and maintain its concentration at low level ( < 1 μM) thus to protect neurons from excitotoxicity caused by Glu1. Up to now, five subtypes of glutamate transporter GLAST (EAAT1)2, GLT-1 (EAAT2)3, EAAC1 (EAAT3)4, EAAT45 and EAAT56 have been cloned. Excitatory amino acid carrier 1 (EAAC1) is a high-affinity Na+-dependent L-glutamate/D, L-aspartate cell-membrane transporter protein. EAAC1 cDNA was originally cloned from rabbit small jejunum4, followed by finding its counterparts in rat 7, 8, 9, mouse10 and human11, 12, 13, 14. Human EAAC1 gene was mapped to 9p24, which was linked to dicarboxylic aminaciduria and neurodegenerative disorders15. Loss of function studies by means of chronic antisense oligonucleotide administration16 and gene knockout17 revealed that EAAC1 deficiency did not lead to neurodegeneration, although EAAC1 was believed to be a neuronal glutamate transporter. Functional EAAC1 was assembled as pentamer in EAAC1 expressed Xenopus oocyte plasma membrane18.
However, genomic organization of EAAC1 was not fully understood, only its partial genomic organization was documented17. During the experiment of screening of mouse EAAC1 cDNA in our lab, a truncated EAAC1 transcript was cloned and named as EAAC2. In order to address the genomic organization relationship between EAAC1 and EAAC2 transcripts, we cloned the mouse genomic fragment for EAAC1, and also identified transcriptional start sites for EAAC1 and EAAC2 by 5′ RACE. We also detected their expressions at transcriptional level by RT-PCR.
MATERIALS AND METHODS
Mouse EAAC1 and EAAC2 cDNA cloning
The method for cloning EAAC1 cDNA and EAAC2 cDNA from the neonatal Balb/C mouse brain cDNA library (Stratagene Cat. No. 937301) was detailed in literature19.
Mouse genomic organization analysis
The mouse genomic library (Stratagene Cat. No. 946309) was screened with EAAC1 full length cDNA as a probe. The positive genomic clones were mapped by suitable restriction endonucleases and subcloned. DNA sequence was analyzed by automatic fluorescent sequencer. The DNA sequence data were aligned and analyzed by GCG software package.
5′ RACE
Poly A+ mRNA was isolated from tissues of neonatal mice and adult mice by OligotexTM mRNA Mini Kit (Qiagen Cat. No.70022). The first-strand cDNA synthesis and 5′ RACE PCR amplification were performed according to manufacturer's instructions (Clontech, Cat. No. K1811-1). For 5′RACE of EAAC1 transcript, P1 primer (All the primers sequence information were listed in Tab 1) was used as EAAC1 gene specific primer in the first round PCR, and P2 primer was used as EAAC1 nest primer in the second round PCR. For 5′ RACE of EAAC2 transcript, P3 primer was used as EAAC2 gene specific primer in the first round PCR, and P4 primer was used as EAAC2 nest primer in the second round PCR. Sequences of 5′ RACE PCR products were analysed directly or after T-Vector cloning by automatic fluorescent sequencer.
RT-PCR
Total RNA was extracted from mice tissues using Trizol reagent (Gibcol BRL), then treated with RNase-free DNase I to eliminate the contaminant of chromosomal DNA. Approximately 5 μg total RNA was converted into the first-strand cDNA using Oligo dT15 as primer. The E. coli RNase H (TaKaRa) was used to remove the RNA templet. The cDNA was used as template in PCR amplification. P5 and P6 primers were used for the specific region of EAAC1 transcript and P7 and P8 primers for PCR amplification of the specific region of EAAC2 transcript. PCR amplification of GAPDH was used as reference that generated by P9 and P10 primers.
RESULTS AND DISCUSSION
Characters of EAAC1 and EAAC2 transcripts
The EAAC1 cDNA that we cloned in this paper is totally in length of 3727 bp. The sequence was deposited in GenBank (U73521). Its open reading frame from nucleotide 76 to 1648 encoded a protein of 523 residues, which was identical to the sequence of EAAC1 protein reported previously10, except amino acid substitution of methinine at site of 141 for isoleucine. Both polyadenylation signal and translational initiation context of EAAC1 transcript were consistent with the consensus sequences. During our cloning EAAC1 cDNA, we obtained a novel cDNA clone with the insertion sequence of 2176 bp. The sequence was deposited in GenBank (U75214) and named as EAAC2. With comparison to EAAC1, EAAC2 had 288 bp specific sequence in 5′ untranslated region, but its rest sequence was identical to EAAC1 except its 3′untranslated region was shortened for 1341 bp. Its open reading frame from nucleotide 296 to 1423 encoded a protein of 375 residues, which was identical to EAAC1 protein from residue 149 to 523 with 148 residues truncated at N-terminal. However, both polyadenylation signal and translational initiation context of EAAC2 transcript were not typical but potential.
The genomic organizations of EAAC1 and EAAC2 transcripts
To further study whether the EAAC2 is a spliced variation of EAAC1 or an independent transcript, we screened the genomic library of mice. Three positive phage clones were fished out by the probe of EAAC1 cDNA. With the overlapping insertion genomic sequence of 18.2 kb, 15.2 kb and 16.2 kb respectively in these three clones, a physical map of 33 kb was constructed . Approximately 25 kb of genomic sequence from Sal I to BamH I was sequenced in order to address the genomic organization relationship between EAAC1 and EAAC2 transcripts, the sequence data of 25407 bp was deposited in Genbank (GenBank AF322393). The genomic organizations of EAAC1 and EAAC2 transcripts were showed in Fig 1 and Tab 2.
The region from nucleotide 309 to 3727 of EAAC1 transcript was distributed into 10 exons, in terms of exon I, II, III, IV, V, VI, VII, VIII, IX, X (Fig 1 and Tab 2). The corresponding genomic sequence from nucleotide 1 to 308 of EAAC1 transcript and its upstream regulation and control sequence were not included in this genomic sequence. All exon and intron junctions were followed the “GT-AG” rule (Tab 2)20. Two polyadenylation signals were located at nucleotide 21614 and nucleotide 21174.
EAAC2 transcript was distributed into 8 exons, in terms of exon β, IV, V, VI, VII, VIII, IX, δ(Fig1 and Tab 2). Among them, exon IV, V, VI, VII, VIII, IX were identical to exons for EAAC1 transcript. Exon β contained the 288 bp specific sequence at 5′untranslated region of EAAC2 transcript and the sequence overlapped with exon III at the 3′ end. Exon d was identical to exon X but with 1310 bp shortened at 3′ end. All exon and intron junctions were consistent with consensus sequence (Tab 2)20. There was no TATA box, CAAT box, CpG Island and octamer consensus sequences upstream from exon β. Its polyadenylation signal AATGAA at nucleotide 20309 was not typical but potential.
Transcriptional start sites of EAAC1 and EAAC2 transcripts
We employed 5′ RACE method to test whether the 5′ sequences of EAAC1 and EAAC2 transcripts were complete, and to identify their transcription start sites. EAAC1 transcript 5′ RACE product with the length of about 150bp was amplified from mRNA of 24 to 36 hours postnatal mice (D1) cortex, D1 kidney, and D1 intestine, of 72 to 96 h postnatal mice (D3) intestine and of one year old mouse whole brain tissue (Fig 2). These sequences fully matched to EAAC1 sequence from nucleotide 1 to 79 and extended 33 bp in 5′ upstream direction as following: 5′ GAATGGCAGC GCTGTACAGC GGCCGGTGCG CGT 3′. Since the genomic sequence corresponding the region from nucleotide1 to 308 of EAAC1 transcript did not locate in our genomic sequence, we were not able to analyze the transcriptional start sites of EAAC1 transcript. The fact that both additional sequence and additional length (Tab 3) were identical in all products from different source indicated that EAAC1 transcript was transcribed from a unique transcriptional start site.
The DNA fragments of 5′ RACE of EAAC2 transcript were in the length of 200 bp to 300 bp from the mRNA of D1 cerebral cortex, D1 kidney, D3 intestine and one year old mouse whole brain (Fig 2). Sequence analysis showed that they were perfectly identical to not only nucleotide 1 to 100 of EAAC2 transcript, but also the genomic sequence in consecutive. The additional length of EAAC2 5′ RACE product in 5′ upstream direction was 89 bp in the mRNA of D1 cerebral cortex, 45 bp in D1 kidney, 65 bp in D3 intestine and 120 bp in one-year-old mouse whole brain (Tab 3). The genomic contexts surrounding the 5′ first nucleotides in EAAC2 5′ RACE additional sequences were not consistent with splicing consensus sequences 20, which indicated that EAAC2 transcript was not the product of alternative splicing and supported that EAAC2 was initiated at different transcriptional start sites to that of EAAC1 in tested tissues. Combining of the result of genomic organization analysis, it does not seem that the transcript of EAAC1 and EAAC2 are created by the same promoter from different transcriptional start sites. We believe that the EAAC2 transcription is initiated from an independent promoter different from that of EAAC1.
Expressions of EAAC1 and EAAC2 transcripts at transcriptional level
RT-PCR with EAAC1 and EAAC2 5′specific primers indicated that both EAAC1 and EAAC2 were expressed in cerebral cortex, hippocampus, cerebellum, brain stem, lung and kidney tissues of D3 neonatal mouse (Fig 3).
In this paper we reported a new cDNA clone (EAAC2) encoding a N-terminal truncated EAAC1 protein was found. We also proved that EAAC2 transcription was initiated from its own promoter other than an alternative splicing of EAAC1. The expression pattern of EAAC2 is nearly identical in spatio-temporal manner to that of EAAC1. We expressed EAAC2 cDNA in Xenopus oocyte by infecting cDNA of EAAC2 to measure if it could be Glu transporter, the answer was no (data not shown). We also co-expressed EAAC1 and EAAC2 in oocyte to see if EAAC2 had effect on the function of EAAC1, but no effect of EAAC2 was found on the function of EAAC1 (data not shown). To address the question that what is the biological function of EAAC2 is a big challenge to our further work.
References
Kanai Y . Family of neutral and acidic amino acid transporters: molecular biology, physiology and medical implications. Curr Opin Cell Biol 1997; 9:565–72.
Storck T, Schulte S, Hofmann K, Stoffel W . Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci USA 1992; 89:10955–9.
Pines G, Danbolt NC, Bjoras M, Zhang Y, Bendahan A, Eide L, et al. Cloning and expression of a rat brain L-glutamate transporter [published erratum appears in Nature 1992 Dec 24-31;360(6406):768] [see comments]. Nature 1992; 360:464–7.
Kanai Y, Hediger MA . Primary structure and functional characterization of a high-affinity glutamate transporter [see comments]. Nature 1992; 360:467–71.
Fairman WA, Vandenberg RJ, Arriza JL, Kavanaugh MP, Amara SG . An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 1995; 375:599–603.
Arriza JL, Eliasof S, Kavanaugh MP, Amara SG . Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci USA 1997; 94:4155–60.
Bjoras M, Gjesdal O, Erickson JD, Torp R, Levy LM, Ottersen OP, et al. Cloning and expression of a neuronal rat brain glutamate transporter. Brain Res Mol Brain Res 1996; 36:163–8.
Kiryu S, Yao GL, Morita N, Kato H, Kiyama H . Nerve injury enhances rat neuronal glutamate transporter expression: identification by differential display PCR. J Neurosci 1995; 15:7872–8.
Velaz FM, McGraw TS, alandro MS, Fremeau-RT J, Kilberg MS, Anderson KJ . Characterization and distribution of the neuronal glutamate transporter EAAC1 in rat brain. Am J Physiol 1996; 270:C67–C75.
Mukainaka Y, Tanaka K, Hagiwara T, Wada K . Molecular cloning of two glutamate transporter subtypes from mouse brain. Biochim Biophys Acta 1995; 1244:233–37.
Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP, Amara SG . Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci 1994; 14:5559–69.
Kanai Y, Stelzner M, Nussberger S, Khawaja S, Hebert SC, Smith CP, et al. The neuronal and epithelial human high affinity glutamate transporter. Insights into structure and mechanism of transport. J Biol Chem 1994; 269:20599–606.
Kanai Y, Nussberger S, Romero MF, Boron WF, Hebert SC, Hediger MA . Electrogenic properties of the epithelial and neuronal high affinity glutamate transporter. J Biol Chem 1995; 270:16561–68.
Shashidharan P, Huntley GW, Meyer T, Morrison JH, Plaitakis A . Neuron-specific human glutamate transporter: molecular cloning, characterization and expression in human brain. Brain Res 1994; 662:245–50.
Smith CP, Weremowicz S, Kanai Y, Stelzner M, Morton CC, Hediger MA . Assignment of the gene coding for the human high-affinity glutamate transporter EAAC1 to 9p24: potential role in dicarboxylic aminoaciduria and neurodegenerative disorders. Genomics 1994; 20:335–6.
Rothstein JD, Dykes HM, Pardo CA, Bristol LA, Jin L, Kuncl RW, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996; 16:675–86.
Peghini P, Janzen J, Stoffel W . Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration. EMBO J 1997; 16:3822–32.
Eskandari S, Kreman M, Kavanaugh MP, Wright EM, Zampighi GA . Pentameric assembly of a neuronal glutamate transporter. Proc Natl Acad Sci USA 2000; 97:8641–46.
Peng Jibing, Fei Jian, Huang Fang, Jin Xiaoping, Gu Quanbao, Guo Lihe . Cloning and Analyzing of Members of Excitatory Amino Acid Transporter Family From Neonatal Mouse Brain. Acta Biologiae Experimentalis Sinica 2000; 33(1):53–62.
Breathnach R, Chambon P . Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem 1981; 50:349–83.
Acknowledgements
This research was supported by foundations from Chinese Academy of Sciences and Special Funds for Major State Basic Research of China (G19990539).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
JIN, X., PENG, J., HUANG, F. et al. A mRNA molecule encoding truncated excitatory amino acid carrier 1 (EAAC1) protein (EAAC2) is transcribed from an independent promoter but not an alternative splicing event. Cell Res 12, 257–262 (2002). https://doi.org/10.1038/sj.cr.7290132
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.cr.7290132
Keywords
This article is cited by
-
Assessing carrying capacity of regional water resources in karst areas, southwest China: a case study
Environment, Development and Sustainability (2023)
-
Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy
CNS Drugs (2020)
-
Glutamate Transporters (EAAT-1–3) as a Factor in the Pathogenesis and a Potential Therapeutic Target in Epilepsy
Neuroscience and Behavioral Physiology (2020)
-
Cancer prevention trial of a synergistic mixture of green tea concentrate plus Capsicum (CAPSOL-T) in a random population of subjects ages 40-84
Clinical Proteomics (2014)
-
Isoforms of the neuronal glutamate transporter gene, SLC1A1/EAAC1, negatively modulate glutamate uptake: relevance to obsessive-compulsive disorder
Translational Psychiatry (2013)